[email protected]

[[email protected] @mastiffish]

@111BEN_111 Need the mature tnbc data before release, early in the trial they stated they were still finding optimal dose.
During the trial maximum cumulative dose was removed.
We need to wait for patients being on drug longer now before we have complete data.

[[email protected] @mastiffish]

@AndyBurnhamGM He's a spineless wetwipe, who has let our country be over run by feral immigrants.

The last person anyone would want making decisions.

[[email protected] @mastiffish]

@DrRitaDed What planet are u living on?

[[email protected] @mastiffish]

@Keir_Starmer To be raped murdered and fund these animals life's.
THIS IS TREASON.

[[email protected] @mastiffish]

@Keir_Starmer Your spineless, don't have the balls to stand up for your country!
Nobody should be in a position of power such as a prime minister and not have balls to stand up for its people. These are the people you serve.
Yet you on your WATCH have allowed our men women and children...

[[email protected] @mastiffish]

@Blueberrymgmnt @BenHarper121292 In my view, the dose optimization for STS &TNBC has lengthened this timeline/window.
I also think the removal of the lifetime cumulative limit was part of the dose optimization as they weren't seeing the efficacy they were expecting,
Potential partners are waiting for TNBC data

[[email protected] @mastiffish]

@asininitybeyond 👌

[[email protected] @mastiffish]

@111BEN_111 I'm of the view that if there was any other partial response they would have been shouting it from the roof tops, always hopeful there could be a few surprises in the data.

[[email protected] @mastiffish]

@111BEN_111 Can't imagine there will be any improvement on PR, as they would have been RNS'd. So ORR will be low.
how low will depend on patient numbers. The real benift is pfs obviously looking for no median yet and hopefully more minor responses, with an excellent continued safety profile

[[email protected] @mastiffish]

@Blueberrymgmnt What would you class as excellent P1b data?

Unlikey to see any increase in known ORR (any other PR would have been in RNS)

Would expect more minor responses.

No median progression free survival reached.

Expecting excellent safety (which has come to be the norm)

[[email protected] @mastiffish]

@AlanJLSmith 👌

[[email protected] @mastiffish]

@tom_the_bomb__ @RAH00084 @111BEN_111 Eliot fosters Immunocore I'm sure

[[email protected] @mastiffish]

@tom_the_bomb__ #AVCT
things can move really fast

Fortysevens share price rose 1700% in 6 months from $5.53-$95.5

Immunomedics share price rose 1000% in 6 months from $8.80-$87.86

Trillium share price rose 300% over a weekend
From $5.83-$17.72